SHERWIN WILLIAMS CO (SHW) Insider Transactions

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.950 to $362.065, inclusive. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F3 These options were granted on October 18, 2021, pursuant to the terms of a stock option agreement under the 2006 Equity and Performance Incentive Plan (Amended and Restated as of April 19, 2017). The options vested annually in three substantially equal installments commencing October 18, 2022.

F4 These options were granted on February 18, 2020, pursuant to the terms of a stock option agreement under the 2006 Equity and Performance Incentive Plan (Amended and Restated as of April 19, 2017). The options vested annually in three substantially equal installments commencing February 18, 2021.

References: F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.950 to $362.065, inclusive. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F3 These options were granted on October 18, 2021, pursuant to the terms of a stock option agreement under the 2006 Equity and Performance Incentive Plan (Amended and Restated as of April 19, 2017). The options vested annually in three substantially equal installments commencing October 18, 2022.

F4 These options were granted on February 18, 2020, pursuant to the terms of a stock option agreement under the 2006 Equity and Performance Incentive Plan (Amended and Restated as of April 19, 2017). The options vested annually in three substantially equal installments commencing February 18, 2021.

References: F3

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.950 to $362.065, inclusive. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F3 These options were granted on October 18, 2021, pursuant to the terms of a stock option agreement under the 2006 Equity and Performance Incentive Plan (Amended and Restated as of April 19, 2017). The options vested annually in three substantially equal installments commencing October 18, 2022.

F4 These options were granted on February 18, 2020, pursuant to the terms of a stock option agreement under the 2006 Equity and Performance Incentive Plan (Amended and Restated as of April 19, 2017). The options vested annually in three substantially equal installments commencing February 18, 2021.

References:

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.950 to $362.065, inclusive. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F3 These options were granted on October 18, 2021, pursuant to the terms of a stock option agreement under the 2006 Equity and Performance Incentive Plan (Amended and Restated as of April 19, 2017). The options vested annually in three substantially equal installments commencing October 18, 2022.

F4 These options were granted on February 18, 2020, pursuant to the terms of a stock option agreement under the 2006 Equity and Performance Incentive Plan (Amended and Restated as of April 19, 2017). The options vested annually in three substantially equal installments commencing February 18, 2021.

References:

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.950 to $362.065, inclusive. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F3 These options were granted on October 18, 2021, pursuant to the terms of a stock option agreement under the 2006 Equity and Performance Incentive Plan (Amended and Restated as of April 19, 2017). The options vested annually in three substantially equal installments commencing October 18, 2022.

F4 These options were granted on February 18, 2020, pursuant to the terms of a stock option agreement under the 2006 Equity and Performance Incentive Plan (Amended and Restated as of April 19, 2017). The options vested annually in three substantially equal installments commencing February 18, 2021.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.950 to $362.065, inclusive. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F3 These options were granted on October 18, 2021, pursuant to the terms of a stock option agreement under the 2006 Equity and Performance Incentive Plan (Amended and Restated as of April 19, 2017). The options vested annually in three substantially equal installments commencing October 18, 2022.

F4 These options were granted on February 18, 2020, pursuant to the terms of a stock option agreement under the 2006 Equity and Performance Incentive Plan (Amended and Restated as of April 19, 2017). The options vested annually in three substantially equal installments commencing February 18, 2021.

References:

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported total includes 42.73 additional shares of Common Stock acquired by the Reporting Person, since February 17, 2026, via dividend reinvestment.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.500 to $345.795, inclusive. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F4 These options were granted on February 13, 2018 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions.

References: F4

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported total includes 42.73 additional shares of Common Stock acquired by the Reporting Person, since February 17, 2026, via dividend reinvestment.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.500 to $345.795, inclusive. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F4 These options were granted on February 13, 2018 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions.

References: F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported total includes 42.73 additional shares of Common Stock acquired by the Reporting Person, since February 17, 2026, via dividend reinvestment.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.500 to $345.795, inclusive. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F4 These options were granted on February 13, 2018 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions.

References:

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported total includes 42.73 additional shares of Common Stock acquired by the Reporting Person, since February 17, 2026, via dividend reinvestment.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.500 to $345.795, inclusive. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F4 These options were granted on February 13, 2018 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions.

References:

Reported filing row; may be amended. Do not sum filings blindly.

F1 The reported total includes 42.73 additional shares of Common Stock acquired by the Reporting Person, since February 17, 2026, via dividend reinvestment.

F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $345.500 to $345.795, inclusive. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F4 These options were granted on February 13, 2018 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F2 These options were granted on October 18, 2017 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions.

References: F2

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F2 These options were granted on October 18, 2017 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions.

References:

Reported filing row; may be amended. Do not sum filings blindly.

F1 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

F2 These options were granted on October 18, 2017 and vested in three substantially equal installments on each of the first three anniversaries of the date of grant, subject to vesting conditions.

References:

Reported filing row; may be amended. Do not sum filings blindly.

F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $350.390 to $350.525 per share. The Reporting Person undertakes to provide to The Sherwin-Williams Company, any security holder of The Sherwin-Williams Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 Represents the number of shares of Common Stock attributable to the Reporting Person's participation in The Sherwin-Williams Company 401(k) Plan per the trustee's 9/30/2026 statement.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions.

References: F1

Reported filing row; may be amended. Do not sum filings blindly.

F1 These options were granted on October 20, 2026, pursuant to the terms of a stock option agreement under the 2025 Equity and Incentive Compensation Plan. The options vest annually in three substantially equal installments commencing October 20, 2027, subject to vesting conditions.

References: F1